LYMPHOMA & MYELOMA CONNECT is an international group of experts in the field of hematological malignancies and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.

Meet the experts

What’s new from LYMPHOMA & MYELOMA CONNECT

Oncology Hemostasis and bleeding disorders Hemato-oncology 
Update From ASH 2022

Highlights from the ASH Annual Meeting

Experts
Dr Matthew J. Matasar
  • clock 4 MIN
  • calendar Dec 2022

Educational programme supported by an independent medical education grant from COR2ED.
Hemato-oncology 
Update from ASCO 2022 – Myeloma

Dr Hans Lee summarises the highlights from the phase 3 DETERMINATION trial: Lenalidomide, bortezomib, and dexamethasone (RVd) ± autologous stem cell transplantation (ASCT) and R maintenance to progression for newly diagnosed multiple myeloma (NDMM)

Experts
Asst. Prof. Hans Lee
  • clock 2 MIN
  • calendar May 2022

podcast Podcast

Episode

3

of 3

episode
Hemato-oncology 
Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics

Episode 3: Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics

Experts
Assoc. Prof. María Victoria Mateos, Dr Alexander M Lesokhin
  • download Downloadable
    Resouces
  • clock 20 MIN
  • calendar Mar 2022

Educational programme supported by an independent medical education grant from Karyopharm
Hemato-oncology 
Lymphoma Update from ASH 2021

Dr. Matthew J. Matasar summarises the highlights in lymphoma from ASH 2021, including POLARIX, CAR-T in LBCL and mosunetuzumab in FL

Experts
Dr Matthew J. Matasar
  • download Downloadable
    Resouces
  • clock 5 MIN
  • calendar Dec 2021

Educational programme supported by an independent medical education grant from Bayer
Hemato-oncology 
DLBCL Review Paper Published in The Oncologist

Authored by LYMPHOMA & MYELOMA CONNECT members, the paper ‘Translating the Biology of Diffuse Large B-cell Lymphoma into Treatment’ provides an overview of recent advances in DLBCL biology and how they can be translated into clinical care.

Experts
Dr Matthew J. Matasar, Dr Massimo Magagnoli, Prof. Alexey V Danilov
  • download Downloadable
    Resouces
  • clock 5 MIN
  • calendar Nov 2021

Educational programme supported by an independent medical education grant from Bayer
Hemato-oncology 
Update from the 2021 Autumn Congresses in Multiple Myeloma

Dr Claudio Cerchione summarises highlights from SOHO, SOHO Italy and IMW 2021

Experts
Dr Claudio Cerchione
  • download Downloadable
    Resouces
  • clock 10 MIN
  • calendar Nov 2021

Educational programme supported by an independent medical education grant from Karyopharm